Loading clinical trials...
Loading clinical trials...
Patient-derived Organoid Model and Circulating Tumor Cells for Treatment Response of Lung Cancer (CTMS 18-0056)
Conditions
Interventions
Lung Tumor Resection
Locations
1
United States
UT Health San Antonio, M.D. Anderson Cancer Center
San Antonio, Texas, United States
Start Date
October 16, 2018
Primary Completion Date
December 1, 2028
Completion Date
December 1, 2029
Last Updated
January 7, 2025
NCT07143110
NCT06885697
NCT04577599
NCT06974604
NCT07035587
NCT06158971
Lead Sponsor
The University of Texas Health Science Center at San Antonio
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions